New Delhi, April 28
Days after the ICMR announced indigenous Covaxin worked against the Sars-Cov2 double mutant 617, the US too has endorsed its effectiveness. The mutant, as per the World Health Organisation (WHO), has been found in at least 17 nations.
White House chief medical adviser and leading pandemic expert Anthony Fauci said Covaxin, a Bharat Biotech-ICMR vaccine, had been found to neutralise variant 617. The ICMR had on April 21 said Covaxin worked against the double mutant. The WHO, meanwhile, has urged India to fill critical gaps in essential medical supplies. — TNS
Covishield price for states cut to Rs 300
new delhi: The Serum Institute of India on Wednesday announced a 25 per cent cut in the price of Covishield vaccine for states, saying it will charge them Rs 300 a dose instead of Rs 400 for adult vaccination orders after May 1. The SII has not reduced prices for private hospitals —Rs 600 a dose. — TNS
Join Whatsapp Channel of The Tribune for latest updates.